The UK is a powerhouse of clinical research but maintaining that leading position – and all the benefits that come with it – in the face of global change requires adaptation.
The UK is in the grips of election fever, but whoever takes the reins on 13 December will need to “build a thriving environment for medicines discovery” if they want to improve health outco
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
